Sanofi SA (SNYNF)
94.00
-0.25
(-0.27%)
USD |
OTCM |
Apr 24, 16:00
Sanofi Price: 94.00 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 95.00 | 95.00 | 94.00 | 94.00 | 310.00 |
| Apr 23, 2024 | 94.25 | 94.25 | 94.25 | 94.25 | 482.00 |
| Apr 22, 2024 | 92.70 | 92.70 | 92.70 | 92.70 | 0.000 |
| Apr 19, 2024 | 92.70 | 92.70 | 92.70 | 92.70 | 0.000 |
| Apr 18, 2024 | 92.70 | 92.70 | 92.70 | 92.70 | 600729.0 |
| Apr 17, 2024 | 92.23 | 92.70 | 91.48 | 92.70 | 1429.00 |
| Apr 16, 2024 | 91.34 | 92.12 | 91.34 | 92.12 | 2296.00 |
| Apr 15, 2024 | 92.41 | 92.97 | 92.41 | 92.97 | 633.00 |
| Apr 12, 2024 | 92.90 | 92.90 | 92.90 | 92.90 | 0.000 |
| Apr 11, 2024 | 93.40 | 93.40 | 92.90 | 92.90 | 884.00 |
| Apr 10, 2024 | 94.25 | 94.25 | 94.25 | 94.25 | 1295.00 |
| Apr 09, 2024 | 94.26 | 94.26 | 94.26 | 94.26 | 693.00 |
| Apr 08, 2024 | 94.76 | 94.76 | 94.00 | 94.00 | 1566.00 |
| Apr 05, 2024 | 94.40 | 94.40 | 92.69 | 92.69 | 239.00 |
| Apr 04, 2024 | 97.65 | 97.65 | 96.10 | 96.10 | 2326.00 |
| Apr 03, 2024 | 97.65 | 97.65 | 97.65 | 97.65 | 0.000 |
| Apr 02, 2024 | 97.65 | 97.65 | 97.65 | 97.65 | 0.000 |
| Apr 01, 2024 | 97.65 | 97.65 | 97.65 | 97.65 | 0.000 |
| Mar 28, 2024 | 98.53 | 98.53 | 97.65 | 97.65 | 1506.00 |
| Mar 27, 2024 | 99.70 | 99.70 | 99.70 | 99.70 | 691.00 |
| Mar 26, 2024 | 99.96 | 99.96 | 99.96 | 99.96 | 0.000 |
| Mar 25, 2024 | 95.25 | 99.96 | 95.25 | 99.96 | 42171.00 |
| Mar 22, 2024 | 93.72 | 93.72 | 93.72 | 93.72 | 1039.00 |
| Mar 21, 2024 | 95.00 | 95.22 | 95.00 | 95.22 | 749.00 |
| Mar 20, 2024 | 94.87 | 94.87 | 94.87 | 94.87 | 379.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
73.36
Minimum
Sep 23 2022
115.00
Maximum
Apr 11 2022
97.59
Average
99.16
Median
Price Benchmarks
| DBV Technologies SA | 0.70 |
| Cellectis SA | 2.51 |
| PHAXIAM Therapeutics SA (DELISTED) | 3.10 |
| Genfit SA | 3.40 |
Price Related Metrics
| PE Ratio | 20.06 |
| PS Ratio | 2.340 |
| Price to Book Value | 1.434 |
| Earnings Yield | 4.99% |
| Market Cap | 117.36B |
| Operating PE Ratio | 10.46 |
| Normalized PE Ratio | 14.80 |